首页|期刊导航|肝胆胰外科杂志|混合型肝细胞-胆管癌临床病理特征及根治术后预后的倾向性评分匹配分析

混合型肝细胞-胆管癌临床病理特征及根治术后预后的倾向性评分匹配分析OA

Clinicopathological characteristics and prognosis after surgical resection in patients with combined hepatocellular-cholangiocarcinoma:A propensity score matching analysis

中文摘要英文摘要

目的 分析混合型肝细胞-胆管癌(cHCC-CCA)患者的临床病理特征并分析其根治术后的预后.方法 回顾性收集2018年1月至2022年12月期间于中国人民解放军总医院肝病医学部接受根治性切除术的160例原发性肝癌患者的临床资料,按肿瘤病理类型分为三组:cHCC-CCA组(n=40)、肝内胆管癌(ICC)组(n=40)和肝细胞癌(HCC)组(n=80),比较三组患者的临床病理特征.采用倾向性评分匹配(PSM)法对cHCC-CCA组与ICC组、cHCC-CCA组与HCC组分别进行1∶1匹配,比较PSM前后各组患者基线资料以及PSM后各组间生存差异.结果 PSM前,三组在肝炎病毒感染率、甲胎蛋白(AFP,≥100 ng/mL)与糖类抗原199(CA199,≥37 U/mL)阳性率、肝硬化、淋巴结转移、肿瘤分化程度及淋巴结清扫等方面差异有统计学意义(均P<0.05).cHCC-CCA组肝炎病毒感染率、AFP阳性率与HCC组相近,但显著高于ICC组;淋巴结转移率、淋巴结清扫率介于ICC组与HCC组之间(均P<0.05).与HCC组相比,cHCC-CCA组和ICC组术后辅助化疗率较高,介入治疗率及靶向免疫治疗率较低(均P<0.05).cHCC-CCA组与ICC组总生存(OS)期、无复发生存(RFS)期差异无统计学意义(均P>0.05),但两组均显著短于HCC组(P<0.05).PSM后,cHCC-CCA组与ICC组OS和RFS差异均无统计学意义(P>0.05);cHCC-CCA组与HCC组相比,患者中位OS较短[28.0(11.4,49.6)个月vs 50.0(32.5,67.0)个月,P=0.016],RFS差异无统计学意义(P>0.05).结论 cHCC-CCA患者的临床病理特征兼具HCC与ICC的部分特点,手术切除是cHCC-CCA的有效治疗手段.PSM前后,cHCC-CCA与ICC术后OS、RFS均无显著差异,且均显著劣于HCC;PSM后cHCC-CCA中位OS显著劣于HCC,RFS无显著差异.

Objective To analyze the clinicopathological characteristics and the prognosis after surgical resection of combined hepatocellular-cholangiocarcinoma(cHCC-CCA)patients.Methods Clinical data of 160 patients with primary liver cancer who underwent radical resection at Senior Department of Liver Diseases,Chinese PLA General Hospital from January 2018 to December 2022 were retrospectively collected.Patients were divided into three groups according to tumor pathology:the cHCC-CCA group(n=40),the intrahepatic cholangiocarcinoma(ICC)group(n=40),and the hepatocellular carcinoma(HCC)group(n=80).The clinicopathological features of the three groups were compared.Propensity score matching(PSM)was applied to perform 1∶1 matching between the cHCC-CCA group and the ICC group,and between the cHCC-CCA group and the HCC group,respectively.Baseline characteristics before and after PSM,as well as survival differences among groups after PSM,were compared.Results Before PSM,there were significant differences among the three groups in hepatitis virus infection rate,positive rates of alpha protein(AFP,≥100 ng/mL)and carbohydrate antigen 199(CA199,≥37 U/mL),incidence of cirrhosis,lymph node metastasis,tumor differentiation,and performance of lymph node dissection(all P<0.05).The hepatitis virus infection rate and AFP positive rate in the cHCC-CCA group were similar to those in the HCC group,and significantly higher than those in the ICC group.The rates of lymph node metastasis and lymph node dissection in the cHCC-CCA group were intermediate between those in the ICC and HCC groups(all P<0.05).Compared with the HCC group,the cHCC-CCA and ICC groups had higher rates of postoperative adjuvant chemotherapy,but lower rates of interventional therapy,targeted therapy,and immunotherapy(all P<0.05).There were no significant differences in overall survival(OS)or recurrence-free survival(RFS)between the cHCC-CCA and ICC groups(both P>0.05),and both were significantly shorter than those in the HCC group(P<0.05).After PSM,there was no significant difference in OS or RFS between the cHCC-CCA and ICC groups(P>0.05).Compared with the HCC group,the cHCC-CCA group had a shorter median OS[28.0(11.4,49.6)months vs 50.0(32.5,67.0)months,P=0.016],with no significant difference in RFS(P>0.05).Conclusion The clinicopathological features of cHCC-CCA patients share characteristics of both HCC and ICC.Surgical resection is an effective treatment for cHCC-CCA.

高远;张搏伦;席清;曹李

航天中心医院肝胆外科,北京 100049航天中心医院肝胆外科,北京 100049中国人民解放军总医院肝病医学部,北京 100039中国人民解放军总医院肝病医学部,北京 100039

医药卫生

混合型肝细胞-胆管癌肝内胆管癌肝细胞癌手术切除临床病理特征预后倾向性评分匹配

combined hepatocellular-cholangiocarcinomaintrahepatic cholangiocarcinomahepatocellular carcinomasurgical resectionclinicopathological characteristicsprognosispropensity score matching

《肝胆胰外科杂志》 2026 (4)

239-246,8

10.11952/j.issn.1007-1954.2026.04.002

评论